Opinion | Who Will Volunteer for Clinical Trials Now?
The erosion of trust will devastate drug trial recruitment
Related Articles
Mechanistic Implications of the Mediterranean Diet in Patients With Newly Diagnosed CD: Multiomic Results From a Prospective Cohort
To decipher the mechanisms underlying the protective role of the Mediterranean diet (MED) in Crohn’s disease (CD), we explored the implications of adherence to MED…
Three Medical Facilities, Three Different Prices For a Typhoid Shot
One patient’s story navigating healthcare price discrepancies
BCG Revaccination Hopes Dim for Tuberculosis Prevention
Trial fails to show impact on keeping youth from sustained infection
FDA OKs Combination for Low-Grade Serous Ovarian Cancer
Avutometinib plus defactinib approved for patients with recurrent, KRAS-mutated disease
White House Releases ‘Skinny’ FY26 Budget Proposal With $33 Billion in HHS Cuts
Cuts include $18 billion to NIH budget
RFK Jr. Unveils Autism Patient Database Project
Medical records and wearables data will be included, raising privacy concerns
No Clear Connection Between Psoriasis and Seborrhoeic Dermatitis
Psoriasis and seborrheic dermatitis are often viewed as overlapping conditions, but a recent investigation found no clear connection between the diseases. The systematic review and…
Focused Ultrasound Matches Prostatectomy for Intermediate-Risk Prostate Cancer
Numerically fewer cases of treatment failure with focal ablation, fewer complications
Modest Trickle of PCI Into Ambulatory Surgery Centers Despite CMS Payment
Shift to standalone centers appears largely regional, with patients selected
Jennifer Litton, MD, on Defining Endpoints for Neoadjuvant Breast Cancer Trials
The recent update to the Standardized Definitions for Efficacy End Points (STEEP) criteria for adjuvant breast cancer (BC) trials included some separately defined endpoints for…